NCT06077890

Brief Summary

This study investigates the effectiveness of SIMPLI.REHAB, a digital tool employed as an interface for administering occupational rehabilitation programs to patients diagnosed with Rheumatoid and Psoriatic Arthritis. Both of these conditions are inflammatory joint disorders capable of causing significant morphofunctional alterations in the hands, especially in their advanced stages. The introduction of digital technology emerges as a complementary tool when implementing rehabilitation programs. Utilizing a prospective, longitudinal, single-blinded experimental study, 35 patients will be allocated into two groups: one receiving a complementary digital intervention through SIMPLI.REHAB and the other through a conventional rehabilitation program. Each group consists of six patients and the program spans seven weeks, focusing on therapeutic exercises, training in manual dexterity, and motor coordination, among other interventions, led by a Physiatrist. The study intends to measure outcomes based on functionality scores, pain, disease activity, joint range, grip, pinch strength, and manual dexterity, both before and after each intervention, in order to ascertain the efficacy of integrating dynamic content through the digital tool SIMPLI.REHAB, as a supplementary resource in occupational rehabilitation programs. The potential limitations of the study include potential losses of follow-up and difficulties in assessing adherence to the digital tool precisely. Nonetheless, the digital tool aims to augment functional gains in rehabilitation programs by providing patients with accessible dynamic content of home-based strategies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 11, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

5 months

First QC Date

September 24, 2023

Last Update Submit

April 28, 2024

Conditions

Keywords

Physical and Rehabilitation MedicineDigital TechnologyOccupational therapyHandRehabilitation

Outcome Measures

Primary Outcomes (2)

  • Disabilities of the Arm, Shoulder and Hand (DASH) Score

    Hand functionality in basic and instrumental daily life activities, occupational and artistic or sports activities, through the score in the Disabilities of the Arm, Shoulder and Hand (DASH) 30-item questionnaire, calculated before and after the intervention. For each question, the patient rates on a 5-point Likert scale. The total score will range from 0 (no disability) to 100 (severe disability). It is a valid and reliable questionnaire (Pearson r \> 0.70; ICC(2,1) = 0.96), with a minimal clinically important difference ranging between 10.83 and 15. (33, 37, 38).

    Average of 7 weeks

  • QuickDASH Outcome Measure

    Shortened version of the DASH questionnaire which includes 11 items for clinical and functional evaluation of the upper limb. The QuickDASH questionnaire assesses an individual's ability to complete daily life activities, the ability to bear load, as well as the intensity of symptoms. It is also a valid and reliable questionnaire (Pearson r \> 0.70; ICC(2,1) = 0.90), with the minimal clinically important difference ranging between 15.91 and 20.

    Average of 7 weeks

Secondary Outcomes (3)

  • Number of Participants with New Osteoarticular Deformities

    Average of 7 weeks

  • Rate of Rescue Medications Usage

    Average of 7 weeks

  • Number of Participants with Assistive Devices

    Average of 7 weeks

Other Outcomes (8)

  • Numeric Pain Scale

    Average of 7 weeks

  • Range of Motion

    Average of 7 weeks

  • Muscular Strength

    Average of 7 weeks

  • +5 more other outcomes

Study Arms (2)

Digital Intervention Group

EXPERIMENTAL

This group incorporates the SIMPLI.REHAB digital tool as a complementary strategy for a rehabilitation program, including flexibility exercises and muscle strengthening, manual dexterity and motor coordination training, thermotherapy, and education on joint protection principles.

Other: Digital Rehabilitation

Conventional Intervention Group

ACTIVE COMPARATOR

This group follows a conventional rehabilitation program delivered in a more traditional, non-digital manner to serve as a comparison to assess the superiority of the experimental intervention using SIMPLI.REHAB digital tool.

Other: Conventional Rehabilitation

Interventions

Participants in this arm will undergo an in-person rehabilitation program coordinated by a Physiatrist and will be able to access home-based rehabilitation strategies through dynamic content provided by SIMPLI.REHAB digital tool.

Digital Intervention Group

Participants in this arm will undergo an in-person rehabilitation program coordinated by a Physiatrist and will be given home-based strategies in a printed paper brochure.

Conventional Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • " Must be referred patients from the Rheumatology Service of CHVNG/E. " Age 18 or older. " Must have a clinical diagnosis of either rheumatoid arthritis or psoriatic arthritis by a Rheumatology specialist, as per the diagnostic criteria of the American College of Rheumatology.
  • " Must present pain, joint stiffness, joint instability, or osteoarticular deformities in the joints of the wrist, hand, and fingers.
  • " Must have a functional impact with a QuickDASH score \> 31.5. " Must be capable of using the SIMPLI.REHAB app on a smartphone with internet connectivity.
  • " Must possess digital literacy allowing the use of the app. " Must have the ability to understand and provide informed consent.

You may not qualify if:

  • "Presence of other medical conditions that might interfere with participation or interpretation of results, such as: neoplasms, other systemic autoimmune diseases, diabetic polyneuropathy and/or uncontrolled diabetes " Having had local surgery on the joint of the wrist, hand, and fingers or a history of fracture in the last 6 months.
  • " History of intra-articular or intramuscular corticoanesthetic infiltration in the previous 4 weeks.
  • " Inability to perform hand exercises due to significant understanding, cognitive, or physical limitation.
  • " Participation in an occupational rehabilitation program during the study period or in the last 6 months.
  • " Severe hearing loss or visual impairment. " Undergoing other types of therapies or localized interventions in the hand and fingers during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Hospitalar de Vila Nova de Gaia-Espinho, E.P.E.

Porto, Vila Nova De Gaia, 4434-502, Portugal

Location

MeSH Terms

Conditions

Arthritis, PsoriaticArthritis, RheumatoidHand DeformitiesMobility Limitation

Condition Hierarchy (Ancestors)

SpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesArthritisJoint DiseasesPsoriasisSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesRheumatic DiseasesConnective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Eugénio M Gonçalves, MD

    Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

    PRINCIPAL INVESTIGATOR
  • Ana M Campolargo, MD

    Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 24, 2023

First Posted

October 11, 2023

Study Start

July 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations